Neurotech Insights
February 29, 2008
Inside This Issue: Post-traumatic Stress Disorder
Top News Alerts: Product Updates, Deals & Financings
Featured Topic: PTSD symptoms and treatments
Featured Company: BrainCells, Inc.
Subscribe now to access hundreds of articles covering developments in drugs, devices and diagnostics for the brain and nervous system.
Market Highlights: Battered Markets Delay Life Science Exits
February marked a dismal month for companies aspiring to the reach the public market. At least six life science companies canceled or postponed their IPO including Archemix, Biolex, Athena Health, Light Sciences Oncology, Transoma, and neurodevice company Concentric Medical. One company, Mako Surgical, succeeded in its offering raising $51 million after a price reduction from $16 to $10. While late stage companies are feeling the heat, early stage companies who have struggled to get venture attention in recent years, are now back in favor according to a panel at the Dow Jones Venture Summit. With exits in the short term limited, venture investors are taking a closer look at companies with longer horizons.
On the Front Lines of Post-traumatic Stress Disorder
Post traumatic stress disorder (PTSD) is a distinctive anxiety disorder triggered by trauma. An estimated 7.7 million Americans suffer from PTSD. PTSD usually occurs some time after the subject was involved in, or witnessed an event involving great physical harm or threats thereof and is more frequent in survivors of traumatic events who experienced intense fear and helplessness during the trauma. There are several types of treatment in development for PTSD including symptom mitigation and secondary prevention during a window of opportunity during or immediately following the event...
BrainCells, Inc.: A Novel Platform for Mood Disorders
BrainCells Inc., a private neuropharmaceutical company located in San Diego, traces its origins to the breakthrough work of Fred "Rusty" Gage at the Salk Institute who discovered that the brain does in fact produce new neurons even in adults. It was a revolutionary discovery that went against the prevailing paradigm dictating that a person is born with all the nerve cells they will ever have...
Companies Covered In This Issue Include: 7TM Pharma, Advanced Cell Technology, Alexza Pharmaceuticals, Allon Therapeutics, Avanir, Bioness, BioLineRx, Depomed, Eli Lilly, Emotiv, EnteroMedics, EpiCept, Evotec, Forest, Jazz Pharma, Labopharm, MediciNova, Neuro-Hitech, Otsuka, Penwest Pharmaceuticals, Prana Biotech, ReNeuron Group, Second Sight Medical, Smart Genetics, Stem Cell Therapeutics, TorreyPines Therapeutics, Valeant, Newron, Hunter-Fleming, Sonexa, Dakim, Cypress Bioscience, Proprius, Concentric Medical, Avera Pharmaceuticals, Brainsway, Acorda Therapeutics, AllTranz, Cyberkinetics, Dynogen, Elan, Envivo Pharmaceuticals, Gastrotech Pharma, Genizon BioSciences, Q Therapeutics, London Genetics, Memory Pharma, Methylgene, Neurometrix, PharmatrophiX, Satiogen Pharmaceuticals, Seaside Therapeutics, Smiths Medical, Solvay, StemCells Inc, StemCyte, Wyeth, Zynex and more.
Subscribe Now:
|
|
